Digidropiridinovye antagonisty kal'tsiya v lechenii arterial'noy gipertonii: novyy predstavitel' – lerkanidipin
- Authors: Galyavich A.S1
-
Affiliations:
- Казанский государственный медицинский университет
- Issue: Vol 9, No 5 (2007)
- Pages: 74-76
- Section: Articles
- URL: https://journal-vniispk.ru/2075-1753/article/view/92392
- ID: 92392
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##References
- Hollman A. Plants in cardiology. Br Med J 1992.
- Rohwedder D, Hacks M. Verapamil. A drug on the threshold of the next decade. Experts in dialoque. Hamburg, Zurich: Wissenschaftsverlag 1992; 9–18.
- Sato M, Nagao T, Yamaguchi I et al. Pharmacological studies on a new 1,5-benzothiazepine derivative (CRD-401). Arzneimittelforschung 1971; 21: 1338–43.
- Triggle D.J. Mechanism of Action of Calcium Channel Antagonists. In: Calcium Antagonists in Clinical Medicine 2nd ed. Epstein M., Hanley&Belfus, 1998.
- Elliot H.L, Meredith P.A, Reid J.L. Pharmacokinetics of Calcium Antagonists: Implications for Therapy. In: Calcium Antagonists in Clinical Medicine 2nd ed. Epstein M., Hanley&Belfus, 1998.
- Toyo - oka T, Nayler W. Third generation calcium entry blockers. Blood pressure 1996; 5: 206–8.
- Barrios V, Navarro A et al. Antihypertensive efficacy and tolerability of lercanidipine in daily clinical practice. The ELYPSE Study. Blood Press 2002; 11 (2): 95–100.
- Fogari R, Mugellini A et al. Differential effects of lercanidipine and nifedipine GITS on plasma norepinephrine in chronic treatment of hypertension. Am J Hypertens 2003; 16 (7): 596–9.
- Pedrinelli R, Dell'Omo G et al. Heterogeneous effect of calcium antagonists on leg oedema: a comparison of amlodipine versus lercanidipine in hypertensive patients. J Hypertens 2003; 21 (10): 1969–73.
- Millar-Craig M, Shaffu B et al. Lercanidipine vs lacidipine in isolated systolic hypertension. J Hum Hypertens 2003; 17 (11): 799–806.
- Borghi C, Prandin M.G et al. Improved tolerability of the dihydropyridine calcium - channel antagonist lercanidipine: the lercanidipine challenge trial. Blood Press Suppl 2003; 1: 14–21.
- James I, Jones A, Davies P. A randomised, double - blind, double - dummy comparison of the efficacy and tolerability of lercanidipine tablets and losartan tablets in patients with mild to moderate essential hypertension. J Human Hypertens 2002; 16: 605–10.
- Poncelet P, Ribstein J et al. Efficacy and acceptability of lercanidipine are not age dependent in patients with essential hypertension: the AGATE study. Ann Cardiol Angeiol (Paris) 2004; 53 (3): 123–30.
- Wirtz S, Herzig S. Molecular mechanisms of vasoselectivity of the 1,4-dihydropyridine lercanidipine Br J Pharm 2004; 142: 275–84.
Supplementary files
